Safety and immunogenicity of the heterologous prime-boost Ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN® FILO in healthy UK adults. Issue 6 (December 2015) - Rampling, Tommy; Ewer, Katie; Bowyer, Georgina; Wright, Danny; Venkatraman, Navin; Payne, Ruth; Nicosia, Alfredo; Sullivan, Nancy; Graham, Barney; Pollard, Andrew; Draper, Simon; Ballou, Ripley; et al.